Patterns of progression in patients treated for immuno-oncology antibodies combination.
Cancer Immunol Immunother
; 70(1): 221-232, 2021 Jan.
Article
in En
| MEDLINE
| ID: mdl-32700090
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Antineoplastic Agents, Immunological
/
Melanoma
/
Antibodies
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2021
Type:
Article